Alexis Romero (Philstar.com) – June 22, 2021 – 8:14pm MANILA, Philippines — Russia’s Gamaleya Institute, the manufacturer of COVID-19 vaccine Sputnik V, wants its emergency use authorization (EUA) amended to lengthen the interval between the two doses of its jab, the Food and Drug Administration (FDA) said. “They (Gamaleya) have already written us to say that they might be amending the emergency use authorization to extend the time interval between the two doses,” FDA director general Eric Domingo said during a meeting of the government’s pandemic task force last Monday. “This is very similar ...

管理者
